Skip to main content
CAMP $5.44 +20.89%
CAMP logo

CAMP · Camp4 Therapeutics Corp

Track CAMP — free
$5.44 +0.94 (+20.89%) At close · Aug 14
Market Cap
$341.38M
Shares
62.75M
All earnings calls

Earnings call · FY2024 Q2

Camp4 Therapeutics Corp Q2 FY2024 Earnings Call

Camp4 Therapeutics Corp Q2 FY2024 Earnings Call

Concluded Jun 30, 2024
Jun 30, 2024 32 turns
Period
FY2024 Q2
Runtime
Sources
1 artifact

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Convertible Debt and Refinancing 27 TSP Customer Demand Softness and Inventory Rebalancing 26 Cost-Saving Initiatives and OpEx Reductions 11 Product Launches and Innovation 7 Customer Wins and New Business 6 International Connected Car Growth 6

Management tone

Cautious

Net tone -25 · moderate hedging

Grounding quotes
  • “The company's second quarter for fiscal year 2024 produced mixed results.”
  • “We now expect this inventory rebalancing with our TSP customers to take longer than previously expected.”
  • “there's still a little bit of uncertainty around that channel, where inventory levels are and should be, and the ability of our TSPs to compete in a pretty competitive marketplace”
  • “Consolidated Q2 revenue is $61.7 million, which was below our guidance range.”

Research coverage

1 live source

Switch sources without leaving this page or losing your listening position.

Revenue $0
Diluted EPS -$26.00
Net income -$12.57M

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document